Dr. Ryan Stevens is excited to be on the cutting edge of nasal polyp treatment by offering the SINUVA sinus implant, recently approved by the FDA to treat nasal polyps in adults who have had previous ethmoid sinus surgery (ESS). SINUVA is a non-surgical option that is placed during a routine physician office visit. It is clinically proven to reduce nasal congestion and polyps. Patients with a known hypersensitivity to the mometasone furoate drug or any of the ingredients in SINUVA should not use SINUVA. The area around SINUVA should be monitored by a physician for any signs of bleeding, irritation, infection, or perforation. Dr. Stevens offers a non-surgical procedure for patients who suffer from repeat nasal polyps with SINUVATM (mometasone furoate) Sinus Implant. SINUVA is proven to reduce polyps and nasal congestion and obstruction.
SINUVA is a sinus implant that treats nasal polyps without surgery. During a routine office visit, Dr. Stevens will use topical and/or local anesthesia to numb the patient’s nose and sinuses. SINUVA is then placed in the sinus cavity through the nasal opening.
How SINUVA works Its innovative design provides a 2-in-1 approach: it is designed to open in the sinus cavity and release anti-inflammatory medicine to treat nasal polyps for up to 90 days.
• Significantly reduces nasal obstruction and congestion
• Significantly improves impaired sense of smell
The most common adverse reactions observed in a clinical trial were bronchitis, upper respiratory or middle ear infection, headache, light-headedness, asthma and nose bleed. SINUVA is indicated for adults with nasal polyps who have had ethmoid sinus surgery.